ABBOTT MEDICAL MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT; HEART-VALVE, MECHANICAL
|
Back to Search Results |
|
Model Number 25VAVGJ-515 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Atrial Fibrillation (1729); Pericardial Effusion (3271)
|
Event Date 03/16/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
|
|
Event Description
|
Clinical information: crd_992 - valved grafts pas, patient site id: (b)(6).It was reported that on 2023, a 25mm sjm masters series valsalva aortic valved graft was successfully implanted.No concomitant cardiac procedures were performed during the same surgery.There were no intraprocedural adverse events or device deficiencies reported.On 2023, the patient was discharged from hospital.On 2023, the patient was hospitalized for newly onset intermittent atrial fibrillation.On transthoracic echocardiogram, pericardial exudate was observed.A pericardiocentesis was performed urgently, and 700 ml of old, bloody fluid was drained.The patient was hospitalized from 2023, and then again from 2023.No patient consequences were reported.
|
|
Event Description
|
Clinical information: (b)(6) - valved grafts pas, patient site id: (b)(6).It was reported that on (b)(6) 2023, a 25mm sjm masters series valsalva aortic valved graft was successfully implanted.No concomitant cardiac procedures were performed during the same surgery.There were no intraprocedural adverse events or device deficiencies reported.On (b)(6) 2023, the patient was discharged from hospital and was on warfarin for anti-thrombotic treatment.On (b)(6) 2023, the patient was hospitalized for newly onset intermittent atrial fibrillation which was believed to be related to the implant procedure.The anti-arrhythmic medication amiodarone was administered.On transthoracic echocardiogram, pericardial exudate was observed.A pericardiocentesis was performed urgently, and 700 ml of old, bloody fluid was drained.The anti-thrombotic regimen was not adjusted after the pericardial effusion was detected and drained.The patient was hospitalized from (b)(6) 2023, and then again from (b)(6) 2023.No patient consequences were reported.
|
|
Manufacturer Narrative
|
An event of atrial fibrillation and pericardial effusion was reported.A returned device assessment could not be performed as the device remains implanted and was not returned for analysis.Information from the field indicated the reported event o was likely due to the implant procedure.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.
|
|
Search Alerts/Recalls
|
|
|